A3W
5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
| Created: | 2017-08-10 |
| Last modified: | 2021-03-01 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 49 |
| Chiral Atom Count | 0 |
| Bond Count | 52 |
| Aromatic Bond Count | 12 |
Chemical Component Summary | |
|---|---|
| Name | 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine |
| Synonyms | PQR309 |
| Systematic Name (OpenEye OEToolkits) | 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine |
| Formula | C17 H20 F3 N7 O2 |
| Molecular Weight | 411.382 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | Nc1cc(c(cn1)c2nc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F |
| SMILES | OpenEye OEToolkits | 2.0.6 | c1c(c(cnc1N)c2nc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F |
| Canonical SMILES | CACTVS | 3.385 | Nc1cc(c(cn1)c2nc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F |
| Canonical SMILES | OpenEye OEToolkits | 2.0.6 | c1c(c(cnc1N)c2nc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F |
| InChI | InChI | 1.03 | InChI=1S/C17H20F3N7O2/c18-17(19,20)12-9-13(21)22-10-11(12)14-23-15(26-1-5-28-6-2-26)25-16(24-14)27-3-7-29-8-4-27/h9-10H,1-8H2,(H2,21,22) |
| InChIKey | InChI | 1.03 | ADGGYDAFIHSYFI-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB14846 |
|---|---|
| Name | Bimiralisib |
| Description | Bimiralisib is under investigation in clinical trial NCT02723877 (PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)). |
| Synonyms |
|
| CAS number | 1225037-39-7 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL4084907 |
| PubChem | 58507717 |
| ChEMBL | CHEMBL4084907 |














